{
    "Title": "ELISA F29 –A therapeutic efficacy biomarker in Chagas disease: Evaluation in pediatric patients treated with nifurtimox and followed for 4 years post-treatment",
    "URL": "https://doi.org/10.1371/journal.pntd.0011440",
    "Published": "June 23, 2023",
    "Subject_Areas": [
        "Enzyme-linked immunoassays",
        "Chagas disease",
        "Serology",
        "Antibody therapy",
        "Parasitic diseases",
        "Biomarkers",
        "Trypanosoma cruzi",
        "Pediatrics"
    ],
    "Authors": {
        "Rocio Rivero": [
            "Instituto Nacional de Parasitología “Dr Mario Fatala Chaben” ANLIS MALBRÁN, Ministerio de Salud, Buenos Aires, Argentina"
        ],
        "Mónica Inés Esteva": [
            "Instituto Nacional de Parasitología “Dr Mario Fatala Chaben” ANLIS MALBRÁN, Ministerio de Salud, Buenos Aires, Argentina"
        ],
        "Erya Huang": [
            "Bayer US LLC, Whippany, New Jersey, United States"
        ],
        "Leylen Colmegna": [
            "LAT Research, Buenos Aires, Argentina"
        ],
        "Jaime Altcheh": [
            "Hospital de Niños Ricardo Gutiérrez and Instituto Multidisciplinario de Investigación en Patologías Pediátricas (IMIPP), CONICET, Buenos Aires, Argentina",
            "CONICET, Consejo Nacional de Investigaciones Científicas y Técnicas, Buenos Aires, Argentina"
        ],
        "Ulrike Grossmann": [
            "Bayer AG, Research and Development Pharmaceuticals, Berlin, Germany"
        ],
        "Andrés Mariano Ruiz": [
            "Instituto Nacional de Parasitología “Dr Mario Fatala Chaben” ANLIS MALBRÁN, Ministerio de Salud, Buenos Aires, Argentina",
            "CONICET, Consejo Nacional de Investigaciones Científicas y Técnicas, Buenos Aires, Argentina"
        ],
        "on behalf of the CHICO and CHICO SECURE Study Groups": []
    }
}